Skip to main content

Table 1 Patient characteristics

From: Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories

Characteristic Entire Group (n = 30)
Age (years) 57 ± 11
Male gender 24 (80%)
Vital Parameters
 Systolic Blood Pressure (mmHg) 131 ± 24
 Diastolic Blood Pressure (mmHg) 78 ± 17
 Height (cm) 173 ± 12
 Weight (kg) 85 ± 14
CAD Risk Factors
 Diabetes mellitus 10 (33%)
 Hypertension 17 (57%)
 Family History of CAD 7 (23%)
 Current Smoker 13 (43%)
 Hyperlipidemia 14 (47%)
Medications
 Statins 30 (100%)
 Beta-blockers 30 (100%)
 Aspirin 30 (100%)
 Thienopyridine 30 (100%)
 ACE-I or ARB 30 (100%)
Peak Troponin
 Troponin T, ng/ml (n = 25) 7.3 ± 4.5
 Troponin I, ng/ml (n = 5) 39.6 ± 18.2
Primary Treatment
 PCI 28 (94%)a
 Lytics 1 (3%)
 None 1 (3%)b
Infarct Related Artery
 LAD 13 (43%)
 RCA 12 (40%)
 LCx 5 (17%)
  1. CAD coronary artery disease, ACE-inhibitor angiotensin-converting-enzyme inhibitor, PCI percutaneous coronary intervention, LAD left anterior descending coronary artery, RCA right coronary artery, LCx left circumflex coronary artery
  2. aIn 2 patients PCI was not successful
  3. bPresented later than 24 h